 BEDMER, N.J., May 31, 2022 GLOBE NEWSWIRE -- Matinas BioPharma NYSE AMER: MTNB, a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal LNC platform technology, announced today that Jerry Jabbour, Chief Executive Officer, has been invited to present at the LD Micro Invitational XII Conference on Tuesday, June 7, 2022, at 3:30 p.m. ET 12:30 p.m. PT. The conference is being held at the Four Seasons Hotel in Westlake Village, Calif. 